OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in Bacteria-Based Cancer Treatment
Xianyuan Wei, Meng Du, Zhiyi Chen, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4945-4945
Open Access | Times Cited: 23

Showing 23 citing articles:

Microbial Therapy and Breast Cancer Management: Exploring Mechanisms, Clinical Efficacy, and Integration within the One Health Approach
Charalampos Filippou, Sophia Themistocleous, Giorgos Marangos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1110-1110
Open Access | Times Cited: 19

Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Zhaoyou Chu, Wanni Wang, Zheng Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 17, pp. 8847-8877
Closed Access | Times Cited: 15

Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Aref Yarahmadi, M. Amin Zare, Masoomeh Aghayari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14

Studying the Oncolytic Activity of Streptococcus pyogenes Strains Against Hepatoma, Glioma, and Pancreatic Cancer In Vitro and In Vivo
Anna Tsapieva, Alexander N. Chernov, N. V. Duplik, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 76-76
Open Access | Times Cited: 1

Supercharged precision killers: Genetically engineered biomimetic drugs of screened metalloantibiotics against Acinetobacter baumanni
Xianyuan Wei, Bin Xue, Shuangchen Ruan, et al.
Science Advances (2024) Vol. 10, Iss. 12
Open Access | Times Cited: 7

Engineered Microorganisms for Advancing Tumor Therapy
Jinxuan Jia, Xiaocheng Wang, Xiang Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 7

Bacteria and Bacterial Components as Natural Bio-Nanocarriers for Drug and Gene Delivery Systems in Cancer Therapy
Rui Zong, Hainan Ruan, Chan‐Min Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2490-2490
Open Access | Times Cited: 16

The application of bacteria-nanomaterial hybrids in antitumor therapy
Susu Xiao, Min Mu, Chenqian Feng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Breaking barriers in cancer treatment: nanobiohybrids empowered by modified bacteria and vesicles
Muhammad Ijaz, Mohsin Khurshid, Jingsi Gu, et al.
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8759-8777
Closed Access | Times Cited: 4

Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria
Jason M. Roe, Kevin D. Seely, Caleb J. Bussard, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 2004-2004
Open Access | Times Cited: 11

Unveiling the Interplay Between the Human Microbiome and Gastric Cancer: A Review of the Complex Relationships and Therapeutic Avenues
Jenan Al‐Matouq, Hawra Al-Ghafli, Noura N. Alibrahim, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 226-226
Open Access

A biomimetic phototherapeutic nanoagent based on bacterial double-layered membrane vesicles for comprehensive treatment of oral squamous cell carcinoma
Qian Chen, Tianhe Shan, Yanjie Liang, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 47, pp. 11265-11279
Closed Access | Times Cited: 8

Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?
Shubhra Sharma, Himani Sharma, Himanshu Gogoi
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8

Bacterial Therapy of Cancer: A Way to the Dustbin of History or to the Medicine of the Future?
Larisa N. Ikryannikova, Neonila V. Gorokhovets, Darya A. Belykh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9726-9726
Open Access | Times Cited: 6

Nanobiohybrids and Bacterial Carriers: A Novel Pathway to Targeted Cancer Therapy
Diyar Salahuddin Ali, Hazha Omar Othman, Sarhang Hayyas Mohammed, et al.
Nano Futures (2024) Vol. 8, Iss. 3, pp. 032001-032001
Closed Access | Times Cited: 2

Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials
Aroni Chatterjee, Rajni Khan, Triparna Mukherjee, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 11
Closed Access | Times Cited: 1

Unleashing the power of precision drug delivery: Genetically engineered biomimetic nanodrugs incorporating liposomal polypharmacy against multidrug-resistant bacteria
Xianyuan Wei, Jintong Guo, Xiaorui Geng, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154515-154515
Closed Access

Probiotic Bacteria for Targeted Drug Delivery: Potential Applications in Cancer Therapy
Nikita Nikita
International Journal for Research Publication and Seminars (2024) Vol. 15, Iss. 3, pp. 216-224
Open Access

Nueva herramienta biotecnológica para el tratamiento de tumores sólidos cancerosos: transformación genética de bacterias anaerobias
María Alejandra Martínez Delgado, Santiago Andrés Díaz
Revista Colombiana de Biotecnología (2024) Vol. 26, Iss. 2, pp. 63-76
Open Access

Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications
Xianda Zhao, Timothy K. Starr, Subbaya Subramanian
Cancers (2023) Vol. 15, Iss. 16, pp. 4197-4197
Open Access | Times Cited: 1

Роль пробиотиков в профилактике и лечении заболеваний
Ж.С. Байгужина, А.Е. Хасенова, Ш.К. Елеупаева, et al.
Bulletin of the Karaganda University “Biology medicine geography Series” (2023) Vol. 111, Iss. 3, pp. 25-34
Open Access

Page 1

Scroll to top